Panitumumab

Category: Cancer



Panitumumab Overview

Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans). Panitumumab is manufactured by Amgen and marketed as Vectibix. It was originally developed by Abgenix Inc. In 2014, Amgen and Illumina entered into an agreement to develop a companion diagnostic to accompany panitumumab.[1] Contents 1 Uses 2 FDA Approval 3 Mechanism 4 Pharmacokinetics 5 Ad...

Read more Panitumumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Panitumumab

Recent Panitumumab Forums: RSS Feed

tablet related to cancer

yellow in colour,round in shape with diagonal slash in tablet. Name of tablet starts with pan-... ## i want to know tha name of the tablet which is good for abdomen cancer ## That's not a whole lot of information to go on. What country are you in? It can depend on what class of medication it is, too. Is it a chemotherapy drug or other? I found two listed that start with Pan, they are: Panitumumab: and Panretin It also depends on the specific type of cancer, so just saying abdomen cancer doesn't give me a lot to go on. Can you please post back with more information? I'll gladly help further, if I can.

Updated

Possible Dosages for this and Related Drugs:

Panitumumab
  • Injection: 10ml/200mg, 20ml/400mg, 5ml/100mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Panitumumab or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA